» Articles » PMID: 9547344

Tolerization of Anti-Galalpha1-3Gal Natural Antibody-forming B Cells by Induction of Mixed Chimerism

Overview
Journal J Exp Med
Date 1998 May 23
PMID 9547344
Citations 43
Authors
Affiliations
Soon will be listed here.
Abstract

Xenotransplantation could overcome the severe shortage of allogeneic organs, a major factor limiting organ transplantation. Unfortunately, transplantation of organs from pigs, the most suitable potential donor species, results in hyperacute rejection in primate recipients, due to the presence of anti-Galalpha1-3Gal (Gal) natural antibodies (NAbs) in their sera. We evaluated the ability to tolerize anti-Gal NAb-producing B cells in alpha1,3-galactosyltransferase knockout (GalT KO) mice using bone marrow transplantation (BMT) from GalT+/+ wild-type (WT) mice. Lasting mixed chimerism was achieved in KO mice by cotransplantation of GalT KO and WT marrow after lethal irradiation. The levels of anti-Gal NAb in sera of mixed chimeras were reduced markedly 2 wk after BMT, and became undetectable at later time points. Immunization with Gal+/+ xenogeneic cells failed to stimulate anti-Gal antibody production in mixed chimeras, whereas the production of non-Gal-specific antixenoantigen antibodies was stimulated. An absence of anti-Gal-producing B cells was demonstrated by enzyme-linked immunospot assays in mixed KO + WT --> KO chimeras. Thus, mixed chimerism efficiently induces anti-Gal-specific B cell tolerance in addition to T cell tolerance, providing a single approach to overcoming both the humoral and the cellular immune barriers to discordant xenotransplantation.

Citing Articles

Physiological basis for xenotransplantation from genetically modified pigs to humans.

Peterson L, Yacoub M, Ayares D, Yamada K, Eisenson D, Griffith B Physiol Rev. 2024; 104(3):1409-1459.

PMID: 38517040 PMC: 11390123. DOI: 10.1152/physrev.00041.2023.


Progress in islet xenotransplantation: Immunologic barriers, advances in gene editing, and tolerance induction strategies for xenogeneic islets in pig-to-primate transplantation.

Eisenson D, Hisadome Y, Santillan M, Yamada K Front Transplant. 2024; 1.

PMID: 38390384 PMC: 10883655. DOI: 10.3389/frtra.2022.989811.


Antibody production and tolerance to the α-gal epitope as models for understanding and preventing the immune response to incompatible ABO carbohydrate antigens and for α-gal therapies.

Galili U Front Mol Biosci. 2023; 10:1209974.

PMID: 37449060 PMC: 10338101. DOI: 10.3389/fmolb.2023.1209974.


Progress in xenotransplantation: overcoming immune barriers.

Sykes M, Sachs D Nat Rev Nephrol. 2022; 18(12):745-761.

PMID: 36198911 PMC: 9671854. DOI: 10.1038/s41581-022-00624-6.


Progress in Xenotransplantation: Immunologic Barriers, Advances in Gene Editing, and Successful Tolerance Induction Strategies in Pig-To-Primate Transplantation.

Eisenson D, Hisadome Y, Yamada K Front Immunol. 2022; 13:899657.

PMID: 35663933 PMC: 9157571. DOI: 10.3389/fimmu.2022.899657.


References
1.
Okamoto M, Murakami M, Shimizu A, Ozaki S, Tsubata T, Kumagai S . A transgenic model of autoimmune hemolytic anemia. J Exp Med. 1992; 175(1):71-9. PMC: 2119080. DOI: 10.1084/jem.175.1.71. View

2.
Bach F, Robson S, Winkler H, Ferran C, Stuhlmeier K, Wrighton C . Barriers to xenotransplantation. Nat Med. 1995; 1(9):869-73. DOI: 10.1038/nm0995-869. View

3.
Murakami M, Tsubata T, Okamoto M, Shimizu A, Kumagai S, Imura H . Antigen-induced apoptotic death of Ly-1 B cells responsible for autoimmune disease in transgenic mice. Nature. 1992; 357(6373):77-80. DOI: 10.1038/357077a0. View

4.
Sykes M, Abraham V, Harty M, Pearson D . IL-2 reduces graft-versus-host disease and preserves a graft-versus-leukemia effect by selectively inhibiting CD4+ T cell activity. J Immunol. 1993; 150(1):197-205. View

5.
Tiegs S, Russell D, Nemazee D . Receptor editing in self-reactive bone marrow B cells. J Exp Med. 1993; 177(4):1009-20. PMC: 2190975. DOI: 10.1084/jem.177.4.1009. View